Effect of capping agents on the cytotoxicity of silver nanoparticles in human normal and cancer skin cell lines
Source abstract
Abstract
Silver nanoparticles (AgNPs) are among the most widely used nanomaterials in medical and consumer products. However, safety in the uses of AgNPs is still controversial. The toxicity of AgNPs toward various cell types has been reported to depend on the surface properties of the nanoparticles. In this study, the effect of AgNPs with the average size of 5–15 nm on the viability of the CCD-986SK human normal skin fibroblast cell line and A375 human malignant melanoma cell line was evaluated. Comparative toxicity studies, based on MTT assay, were performed by using either sodium alginate or poly (4-styrenesulfonic acid-co-maleic acid) sodium salt (PSSMA) as capping agent in the nanoparticle preparation. The cytotoxicity tests revealed that AgNO3 alone was highly toxic to both cell types while both alginate and PSSMA alone were not toxic. AgNPs capped with alginate were selectively toxic to the cancer cell line but not to the normal cell line while AgNPs capped with PSSMA were toxic to both cancer and normal cell lines. Judging from the 50 % inhibition concentration (IC50), it was found that the cancer cell line was more sensitive to AgNPs than the normal cell line. Study on the mode of cell death by annexin V and propidium iodide staining revealed that AgNPs induced more apoptotic cell death (84–90 %) than necrosis (8–12 %) in the skin cancer cell line. These results suggest that the toxicity of AgNPs depended on the type of capping agent and the type of cell line.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Microplastics and Plastic Pollution
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Albers CE, Hofstetter W, Siebenrock KA, Landmann R, Klenke FM (2013) In vitro cytotoxicity of silver nanoparticles on osteolasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7:30–3610.3109/17435390.2011.626538 ↗
2. Arjmandi N, Van Roy W, Lagae L, Borgh G (2012) Measuring the electric charge and zeta potential of nanometer-sized objects using pyramidal-shaped nanopores. Anal Chem 84:8490–849610.1021/ac300705z ↗
3. Arora S, Tyagi N, Bhardwaj A, Rusu L, Palanki R, Vig K, Singh SR, Singh AP, Palanki S, Miller ME, Carter JE, Singh S (2015) Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomed-Nanotechnol Biol Med 11:1265–127510.1016/j.nano.2015.02.024 ↗
4. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–29010.1021/nn800596w ↗
5. Awasthi KK, Awasthi A, Kumar N, Roy P, Awasthi K, John PJ (2013) Silver nanoparticle induced cytotoxicity, oxidative stress, and DNA damage in CHO cells. J Nanopart Res 15:1898. doi: 10.1007/s11051-013-1898-510.1007/s11051-013-1898-5 ↗
6. Belizario J, Alves J, Occhiucci JM, Malpartida MG, Sesso A (2007) A mechanistic view of mitochondrial death decision pores. Braz J Med Biol Res 40:1011–102410.1590/S0100-879X2006005000109 ↗
7. Chen T, Wong YS, Zheng W, Bai Y, Huang L (2008) Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloid Surface B 67:26–3110.1016/j.colsurfb.2008.07.010 ↗
8. Christensen FM, Johnston HJ, Stone V, Aitken RJ, Hankin S, Peters S, Aschberger K (2010) Nano-silver—feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 4:284–29510.3109/17435391003690549 ↗
9. Cohen MS, Stern JM, Vanni AJ, Kelly RS, Baumgart E, Field D, Libertino JA, Summerhayes IC (2007) In vitro analysis of a nanocrystalline silver-coated surgical mesh. Surg Infect 8:397–40310.1089/sur.2006.032 ↗
10. Dibrov P, Dzioba J, Gosink K, Hase C (2002) Chemiosmotic mechanism of antibacterial activity of Ag+ in Vibrio cholera. Antimicrob Agents Chemother 46:2668–267010.1128/AAC.46.8.2668-2670.2002 ↗
11. El-Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM (2011) Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Techol 45:283–28710.1021/es1034188 ↗
12. Feng Q, Wu J, Chen G, Cui F, Kim T, Kim J (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52:662–66810.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
13. Foldbjerg R, Dang DA, Autrup H (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–75010.1007/s00204-010-0545-5 ↗
14. Gottschalk F, Sonderer T, Scholz RW, Nowack B (2009) Modeled environmental concentrations of engineered nanomaterials (TiO2, ZnO, Ag, CNT, fullerenes) for different regions. Environ Sci Technol 43:9216–922210.1021/es9015553 ↗
15. Han JW, Gurunathan S, Jeong JK, Choi YJ, Kwon DN, Park JK, Kim JH (2014) Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line. Nanoscale Res Lett 9:45910.1186/1556-276X-9-459 ↗
16. Ip M, Lui SL, Poon VK, Lung I, Burd A (2006) Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 55:59–6310.1099/jmm.0.46124-0 ↗
17. Jones CM, Hoek EMV (2010) A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–155110.1007/s11051-010-9900-y ↗
18. Jones SA, Bowler PG, Walker M, Parsons D (2004) Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen 12:288–29410.1111/j.1067-1927.2004.012304.x ↗
19. Jung W, Koo H, Kim K, Shin S, Kim S, Park Y (2008) Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74:2171–217810.1128/AEM.02001-07 ↗
20. Kim S, Ryu DY (2013) Silver nanoparticle-induced oxidative stress, genotoxicity and apoptosos in cultured cells and animal tissues. J Appl Toxicol 33:78–8910.1002/jat.2792 ↗
21. Lee HY, Park HK, Lee YM, Kim K, Park SB (2007) A practical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem Commun (Camb) 28:2959–296110.1039/b703034g ↗
22. Lima RD, Seabra AB, Durán N (2012) Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol 32:867–87910.1002/jat.2780 ↗
23. Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB (2010) Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 4:319–33010.3109/17435390.2010.483745 ↗
24. Moutin MJ, Abramson JJ, Salama G, Dupont Y (1989) Rapid Ag+-induced release of Ca2+ from sarcoplasmic reticulum vesicles of skeletal muscle: a rapid filtration study. Biochim Biophys Acta 984:289–29210.1016/0005-2736(89)90295-2 ↗
25. Mukherjee SG, O’Claonadh N, Casey A, Chambers G (2012) Comparative in vitro cytotoxicity study of silver nanoparticles on two mammalian cell lines. Toxicol in Vitro 26:238–25110.1016/j.tiv.2011.12.004 ↗
26. Orrenius S, McCabe MJ Jr, Nicotera P (1992) Ca2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 64:357–36410.1016/0378-4274(92)90208-2 ↗
27. Pernodet N, Fang X, Sun Y, Bakhtina A, Ramakrishnan A, Sokolov J, Ulman A, Rafailovich M (2006) Adverse effects of citrate/gold nanoparticles on human dermal fibroblast. Small 2:766–77310.1002/smll.200500492 ↗
28. Solomon SD, Bahadory M, Jeyarajasingam AV, Rutkowsky SA, Boritz C (2007) Synthesis and study of silver nanoparticles. J Chem Educ 84:322–32510.1021/ed084p322 ↗
29. Song KC, Lee SM, Park TS, Lee BS (2009) Preparation of colloidal silver nanoparticles by chemical reduction method. Korean J Chem Eng 26:153–15510.1007/s11814-009-0024-y ↗
30. Stickler DJ (2000) Biomaterials to prevent nosocomial infections: is silver the gold standard? Curr Opin Infect Dis 13:389–39310.1097/00001432-200008000-00011 ↗
31. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RH (2007) Functional finishing of carbon fabrics using silver nanoparticles. Nanosci Nanotechnol 7:1893–189710.1166/jnn.2007.737 ↗
32. Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ (2002) Design of biodegradable particles for protein delivery. J Control Release 78:15–2410.1016/S0168-3659(01)00486-2 ↗
33. Wallace WE, Keane MJ, Murray DK, Chisholm WP, Maynard AD, Ong TM (2006) Phospholipid lung surfactant and nanoparticle surface toxicity: lessons from diesel soots and silicate dusts. J Nanopart Res 9:23–3810.1007/s11051-006-9159-5 ↗
34. Wiesner MR, Lowry GV, Alvarez PJJ (2006) Assessing the risks of manufactured nanomaterials. Environ Sci Technol 40:4337–434510.1021/es062726m ↗
35. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van De Meent D, Dekkers S, De Jong WH, Van Zijverden M, Sips AJAM, Geertsma RE (2009) Nano-silver—a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109–13810.1080/17435390902725914 ↗
36. Yang H, Liu C, Yang D, Zhang H, Xi Z (2009) Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol 29:69–7810.1002/jat.1385 ↗